Chantelle Capicciotti

Dr. Chantelle Capicciotti

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
MSM. Osman Sheikh
M. Osman Sheikh
CCChantelle Capicciotti
Chantelle Capicciotti
LLLin Liu
Lin Liu
JPJeremy Praissman
Jeremy Praissman
DDDahai Ding
Dahai Ding
GBGeert-Jan Boons
Geert-Jan Boons
α-Dystroglycan (α-DG) is uniquely modified on O-mannose sites by a repeating disaccharide (-Xylα1,3-GlcAβ1,3-)n termed matriglycan, which is a receptor for laminin-G domain-containing proteins and employed by old-world arenaviruses for infection. Using chemoenzymatically synthesized matriglycans printed as a microarray, we demonstrate length-dependent binding to Laminin, Lassa virus GP1, and the clinically-important antibody IIH6. Utilizing an enzymatic engineering approach, an N-linked glycoprotein was converted into a IIH6-positive Laminin-binding glycoprotein. Engineering of the surface of cells deficient for either α-DG or O-mannosylation with matriglycans of sufficient length recovers infection with a Lassa-pseudovirus. Finally, free matriglycan in a dose and length dependent manner inhibits viral infection of wildtype cells. These results indicate that matriglycan alone is necessary and sufficient for IIH6 staining, Laminin and LASV GP1 binding, and Lassa-pseudovirus infection and support a model in which it is a tunable receptor for which increasing chain length enhances ligand-binding capacity.


4 May 2024 in Current Opinion in Chemical Biology
Verified
Journal Article
Open access
JBJonathan L. Babulic
Jonathan L. Babulic
FGFabiola V. De León González
Fabiola V. De León González
CCChantelle Capicciotti
Chantelle Capicciotti
Glycans decorate all cells and are critical mediators of cellular processes through recognition by glycan-binding proteins (GBPs). While targeting glycan-protein interactions has great therapeutic potential, these interactions are challenging to study as they are generally transient and exhibit low binding affinities. Glycan-based photo-crosslinkable probes have enabled covalent capture and identification of unknown GBP receptors and glycoconjugate ligands. Here, we review recent progress in photo-crosslinking approaches targeting glycan-mediated interactions. We discuss two prominent emerging strategies: 1) development of photo-crosslinkable oligosaccharide ligands to identify GBP receptors; and 2) cell-surface glyco-engineering to identify glycoconjugate ligands of GBPs. Overall, photoaffinity labeling affords valuable insights into complex glycan-protein networks and is poised to help elucidate the glycan-protein interactome, providing novel targets for therapeutic intervention.

13 November 2023 in Glycobiology
Verified
Journal Article
Closed access
PDF file
JKJoshua M Kofsky
Joshua M Kofsky
JBJonathan L Babulic
Jonathan L Babulic
MBMarie E Boddington
Marie E Boddington
FGFabiola V De León González
Fabiola V De León González
CCChantelle Capicciotti
Chantelle Capicciotti
All cells are decorated with complex carbohydrate structures called glycans that serve as ligands for glycan-binding proteins (GBPs) to mediate a wide range of biological processes. Understanding the specific functions of glycans is key to advancing an understanding of human health and disease. However, the lack of convenient and accessible tools to study glycan-based interactions has been a defining challenge in glycobiology. Thus, the development of chemical and biochemical strategies to address these limitations has been a rapidly growing area of research. In this review, we describe the use of glycosyltransferases (GTs) as versatile tools to facilitate a greater understanding of the biological roles of glycans. We highlight key examples of how GTs have streamlined the preparation of well-defined complex glycan structures through chemoenzymatic synthesis, with an emphasis on synthetic strategies allowing for site- and branch-specific display of glyco-epitopes. We also describe how GTs have facilitated expansion of glyco-engineering strategies, on both glycoproteins and cell surfaces. Coupled with advancements in bioorthogonal chemistry, GTs have enabled selective glyco-epitope editing of glycoproteins and cells, selective glycan subclass labeling, and the introduction of novel biomolecule functionalities onto cells, including defined oligosaccharides, antibodies, and other proteins. Collectively, these approaches have contributed great insight into the fundamental biological roles of glycans and are enabling their application in drug development and cellular therapies, leaving the field poised for rapid expansion.

18 March 2022 in Analytical Chemistry
Verified
Journal Article
Closed access
DBDuong T. Bui
Duong T. Bui
JJJaesoo Jung
Jaesoo Jung
EKElena N. Kitova
Elena N. Kitova
ZLZhixiong Li
Zhixiong Li
SWSteven D. Willows
Steven D. Willows
JKJohn S. Klassen
John S. Klassen

23 February 2024 in ACS Chemical Biology
Verified
Journal Article
Closed access
FGFabiola V. De León González
Fabiola V. De León González
MBMarie E. Boddington
Marie E. Boddington
JKJoshua M. Kofsky
Joshua M. Kofsky
MPMartha I. Prindl
Martha I. Prindl
CCChantelle Capicciotti
Chantelle Capicciotti